Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Horizon Therapeutics makes management changes
Ms Grahn was most recently vice president of clinical operations at MedGenesis Therapeutix. At Horizon, Ms Grahn will lead all clinical operations activities. Ms Grahn has a master’s
Ms Grahn was most recently vice president of clinical operations at MedGenesis Therapeutix. At Horizon, Ms Grahn will lead all clinical operations activities. Ms Grahn has a master’s
Mr McCoy will continue to serve on the board as a director. Mr Edgerton has served on the company’s board of directors since February 2007. Mr Edgerton spent
Under the terms of the agreement, Warner Chilcott has exclusive US rights to develop and market the product for the treatment of erectile dysfunction (ED). Dong-A will receive
Valeant develops and markets prescription and nonprescription pharmaceutical products. Valeant specializes in the neurology and dermatology therapeutic areas primarily in the US, Canada, Mexico, Brazil, Australia, and Central
As of the expiration of the tender offer, a total of approximately 73.17 shares of Memory common stock were tendered and not withdrawn, representing approximately 89% of outstanding
This candidate drug is a small molecule that Galapagos has developed in its selective androgen receptor modulator program and which has demonstrated successful proof of concept in animal
The transaction will give Meda exclusive rights to distribute Onsolis in all countries except Taiwan and South Korea for a one-time cash payment to BDSI of $3 million.
The FDA is expected to determine whether to accept the new drug application (NDA) for filing and consider the priority review request within 60 days. If approved, Acura
An agreement via the special protocol assessment (SPA) procedure is an agreement with the FDA that a Phase III clinical trial’s design (endpoints, sample size, control group and
The company noted that certain formalities must be completed before the reissue patent will be granted. The reissued patent will have the same force and effect as the